Epidemiology, clinical characteristics, evolution and treatments in newly diagnosed inflammatory bowel disease (IBD): results from the nationwide EpidemIBD study of GETECCU

Chaparro, M.Barreiro-de Acosta, M.Benitez, J.Cabriada, J.Casanova, M.Ceballos, D.Esteve, M.Fernandez, H.Ginard, D.Gomollon, F.Lorente, R.Nos, P.Riestra, S.Rivero, M.Robledo, P.Rodriguez, C.Sicilia, B.Torrella, E.Garre, A.Rodriguez-Artalejo, F.Garcia-Esquinas, E.Gisbert, J.EpidemIBD Grp2025-01-072025-01-072019-03-011873-9946https://hdl.handle.net/10668/25525enEpidemiology, clinical characteristics, evolution and treatments in newly diagnosed inflammatory bowel disease (IBD): results from the nationwide EpidemIBD study of GETECCUconference outputopen access10.1093/ecco-jcc/jjy222.9141876-4479https://academic.oup.com/ecco-jcc/article-pdf/13/Supplement_1/S516/27599253/jjy222.914.pdf460544503034